Investors and Media


Partnering is a key component of Priavoid´s strategy

We are developing alliances with leading pharmaceutical and biotech companies around the world and are active in talking to potential new partners on our promising pipeline of novel CNS compounds.

Contact us

Please use our contact form if you require any information.